JDRF is the leading global organization funding Type 1 Diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. Funded in 1950 by two mothers who had children with T1D, JDRF is nowdays the largest patient organisation in the world with a focus on people with T1D. JDRF has expertise and established strategic roadmaps in Artificial Pancreas Systems, encapsulation of insulin producing cells, beta cell regeneration, antigen specific immunotherapy, prevention of T1D, prevention or treatment of diabetic complications of the kidney and eye, and other select areas. In 2023, JDRF was selected by European Commission as the only Diabetes Organization for membership to the Health Technology Assessment Stakeholder.
Role within REDDIE
In REDDIE, JDRF will contribute in WP6 with interactions with patient organizations and forming a patient advisory committee.
